Share your knowledge of myeloproliferative neoplasms with fellow physicians

Share your knowledge of MPNs and the role of JAK signaling with fellow physicians

Dear Dr [Last name],

MPNConnect has created the HCP Community in order to further its commitment to improving the understanding of myeloproliferative neoplasms (MPNs). In the Community, you can engage with other medical professionals and share your knowledge through personal email correspondence.

Visit MPNConnect today to gain access to other valuable resources. As a member you can

Download an educational video and brochure on JAK pathway signaling in MPNs
Submit disease-related questions to the Scientific Council
Gain access to selected MPN publications

MPNConnect.org is a scientific educational initiative that aims to advance the understanding of 3 MPNs — myelofibrosis (MF), polycythemia vera (PV) and essential thrombocythemia (ET).

A key area of focus for MPNConnect is dysregulated JAK signaling, which is a common pathogenic mechanism across MF, PV and ET. Multiple abnormalities, such as JAK2 mutations, may cause JAK dysregulation. However, even in the absence of the most common mutation, JAK2V617F, dysregulated JAK signaling can still occur.

To learn more and stay up to date on emerging scientific advances in MPNs, visit MPNConnect today.

Sincerely,
MPNConnect

Incyte Corporation
Commercial Operations Department
Experimental Station
Route 141 & Henry Clay Road
Building E336
Wilmington, DE 19880